SecBot SecBot
S-3 ·Filed Apr 3, 2026

LYEL

Lyell Immunopharma, Inc.
NEUTRAL
Impact 2/10
Horizonweeks Processed7mo ago SEC0001193125-26-142213
Shelf registration, potential dilution
Actionable Insight • Neutral

Monitor for actual sales by the selling stockholders, particularly ARCH Venture Fund, Gates Frontier, and Explore Investments, as these could create downward pressure on the stock. The recent $25M in insider buying suggests confidence in the company's prospects despite this resale registration. The lack of proceeds to the company means this is purely a liquidity event for existing investors rather than a capital raise.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$21.69
T+0 close · Apr 3, 2026 · via day close
Latest settled
−40.20%
T+60 · $12.97
Vs SPY
−53.67%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 6 $21.69entry
  2. T+1 · 7mo ago +0.41%α +0.35% · $21.78
  3. T+5 · 7mo ago +14.34%α +10.20% · $24.80
  4. T+20 · 7mo ago −4.47%α −13.45% · $20.72
  5. T+60 · 5mo ago −40.20%α −53.67% · $12.97
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Lyell Immunopharma has filed an S-3 shelf registration to allow selling stockholders to resell 1,952,360 shares of common stock acquired in a private placement on March 6, 2026. The company will not receive any proceeds from these sales, which were originally purchased at $25.61 per share in a milestone closing. The registration enables liquidity for institutional investors including ARCH Venture Fund, Gates Frontier, and Explore Investments.

Key Financial Metrics

Offering Size
$37.7M
Dilution
8.37%

Key Facts

  • S-3 filing registers 1,952,360 shares for resale by selling stockholders from a March 6, 2026 private placement
  • Company will not receive any proceeds from the resale of these shares
  • Shares were acquired at $25.61 per share in a milestone closing under a July 2025 Securities Purchase Agreement
  • Selling stockholders include ARCH Venture Fund XIII, Euler Fund, Gates Frontier LLC, and Explore Investments LLC
  • Registration fee of $5,200.99 calculated based on $19.29 per share (average of March 27, 2026 Nasdaq high/low)
  • Company recently had $25M in insider buying over the past 30 days

Financial Impact

Potential dilution of 8.4% based on 23,328,390 shares outstanding, with maximum aggregate offering price of $37.66M

dilutionshare countmarket cap

Risk Factors

  • Potential share price pressure if selling stockholders liquidate positions
  • Perception of negative sentiment despite company not receiving proceeds
  • Concentration risk with four primary selling stockholders

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
S-3 Filing (Primary)0001193125-26-142213
Document: d122816dexfilingfees.htm0001193125-26-142213
Document: d122816dex51.htm0001193125-26-142213
Document: d122816dex231.htm0001193125-26-142213
Document: 0001193125-26-142213-index-headers.html0001193125-26-142213
Document: 0001193125-26-142213-index.html0001193125-26-142213
Document: 0001193125-26-142213.txt0001193125-26-142213

Track record

21 reports on LYEL

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +17.99% at T+60 after the Jun 8, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 13, 20263d ago S-3 Neutral 3/10 Entry $14.30 Now $14.65 +2.45% settles Nov 17
  2. Nov 12, 20264d ago Insider Cluster Bullish 6/10 Entry $14.30 to $14.65 Now $14.65 +2.45% ▲ +2.45% +4.36% vs SPY
  3. Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $16.86 to $15.64 Now $14.65 −13.11% ▼ −7.24% −6.88% vs SPY
  4. Nov 5, 202611d ago Insider Cluster Bullish 7/10 Entry $14.86 to $15.42 Now $14.65 −1.41% ▲ +3.77% +1.40% vs SPY
  5. Nov 4, 202612d ago 8-K Neutral 4/10 No price data
  6. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $15.00 to $14.86 Now $14.65 −2.33% ▼ −0.93% −1.25% vs SPY
  7. Nov 4, 202612d ago 8-K Bearish 5/10 Entry $15.43 to $15.00 Now $14.65 +5.06% ▲ +2.79% −1.62% vs SPY
  8. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $15.43 to $15.00 Now $14.65 −5.06% ▼ −2.79% +1.62% vs SPY
  9. Aug 25, 202611w ago Insider Cluster Neutral 4/10 Entry $14.80 to $14.61 Now $14.65 −1.01% ▼ −1.28% −1.94% vs SPY
  10. Jul 22, 202616w ago EFFECT Neutral 4/10 Entry $12.84 to $12.78 Now $14.65 +14.10% ▼ −0.47% +0.77% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 3, 2026